Neuro-Oncology Reviews
Volume
26 Number 26
20 November 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 26, 20 November
Al Shboul S, Singh A, Kobetic R, Goodlett DR, Brennan PM, Hupp T,
Dapic I.
Mass
Spectrometry Advances in Analysis of Glioblastoma.
Mass
Spectrom Rev. 2024 Nov 11. doi:
10.1002/mas.21912. PMID:
39529217. Review˰ ˍ
Lawrence LSP, Maralani PJ, Das S, Sahgal A, Stanisz GJ, Lau AZ.
Magnetic
resonance imaging techniques for monitoring glioma response to
chemoradiotherapy.
J Neurooncol.
2024 Nov 11. doi: 10.1007/s11060-024-04856-3. PMID: 39527382.
Review˰ ˍ
*Rahman R, Preusser M, Tsien C, Le Rhun E, Sulman EP, Wen PY,
Minniti G, Weller M.
Point/Counterpoint:
The role of reirradiation in recurrent glioblastoma.
Neuro
Oncol. 2024 Nov 11:noae209. doi:
10.1093/neuonc/noae209. PMID:
39527460. Perspective. ˍ
Rusak A, Wiatrak B, Krawczyńska K, Górnicki T,
Zagórski K, Zadka Ł, Fortuna W.
Starting
points for the development of new targeted therapies for
glioblastoma multiforme.
Transl
Oncol. 2024 Nov 11;51:102187. doi:
10.1016/j.tranon.2024.102187. PMID:
39531784. Review. ˍ
Suero Molina E, Azemi G, Russo C, Liu S, Di Ieva A.
Artificial
Intelligence in Brain Tumors.
Adv
Exp Med Biol. 2024 Nov 11;1462:201-220. doi:
10.1007/978-3-031-64892-2_12. PMID:
39523267. Book chapter˰
ˍ
Khiabani NA, Doustvandi MA, Story D, Nobari SA, Hajizadeh M,
Petersen R, Dunbar G, Rossignol J.
Glioblastoma
therapy: State of the field and future prospects.
Life
Sci. 2024 Nov 12;359:123227. doi:
10.1016/j.lfs.2024.123227. PMID:
39537100. Review˰ ˍ
Pfeffer LK, Fischbach F, Heesen C, Friese MA.
Current
state and perspectives of CAR T cell therapy in central nervous
system diseases.
Brain.
2024 Nov 12:awae362. doi:
10.1093/brain/awae362. PMID:
39530593. Review˰ ˍ
Rangwala HS, Shafique MA, Mustafa MS, Kumar R, Devi J, Rangwala
BS, Ali SMS, Raja A, Iqbal J, Ali M, Haseeb A.
Evaluating
efficacy and safety of laser interstitial thermal therapy in
patients with newly diagnosed and recurrent glioblastoma: a
systematic review and meta-analysis.
Neurosurg
Rev. 2024 Nov 12;47(1):846. doi:
10.1007/s10143-024-03077-6. PMID:
39528836. Review; Meta-analysis˰
ˍ
Schonfeld E, Choi J, Tran A, Kim LH, Lim M.
The
landscape of immune checkpoint inhibitor clinical trials in
glioblastoma: A systematic review.
Neurooncol
Adv. 2024 Nov 12;6(1):vdae174. doi:
10.1093/noajnl/vdae174. PMID:
39534539. Review. ˍ
Uslu U, June CH.
Beyond
the blood: expanding CAR T cell therapy to solid tumors.
Nat
Biotechnol. 2024 Nov 12. doi:
10.1038/s41587-024-02446-2. PMID:
39533105. Perspective˰
ˍ
Bazer DA, Wolff AC, Grossman SA.
Using
a Pre-Radiation Window to Identify Potentially Active Cytotoxic
Agents in Adults with Newly Diagnosed Glioblastoma.
Neuro
Oncol. 2024 Nov 13:noae240. doi:
10.1093/neuonc/noae240. PMID:
39535058. Review˰ ˍ
Ritchey AK, et al., PDQ
Pediatric Treatment Editorial Board.
Childhood
Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment
(PDQ®): Patient Version.
PDQ
Cancer Inf Summ.
2024
Nov 13. NCBI
Bookshelf ID:
NBK65903. PMID:
26389341. Review.
ˍ
Sabahi M, Fathi Jouzdani A, Sadeghian Z, Dabbagh Ohadi MA, Sultan
H, Salehipour A, Maniakhina L, Rezaei N, Adada B, Mansouri A,
Borghei-Razavi H.
CAR-engineered
NK cells versus CAR T cells in treatment of glioblastoma; strength
and flaws.
J
Neurooncol. 2024 Nov 13. doi:
10.1007/s11060-024-04876-z. PMID:
39538038. Review˰ ˍ
Raali R, Suresh P K.
Unraveling
Glioblastoma: TME Implication and Gene Therapy Advances.
Curr
Gene Ther. 2024 Nov 14. doi:
10.2174/0115665232351747241113050243. PMID:
39543872. Review˰ ˍ
Albert NL, Preusser M.
Theranostics
and molecular imaging in Neuro-Oncology: the beginning of a new
era.
Neuro
Oncol. 2024 Nov 15:noae191. doi:
10.1093/neuonc/noae191. PMID:
39545472. Editorial. ˍ
Rodriguez B, Rivera D, Zhang JY, Brown C, Young T, Williams T,
Kallos J, Huq S, Hadjpanayis C.
Innovations
in intraoperative therapies in neurosurgical oncology: a narrative
review.
J
Neurooncol. 2024 Nov 15. doi:
10.1007/s11060-024-04882-1. PMID:
39546148. Review˰ ˍ
Gunasegaran B, Ashley CL, Marsh-Wakefield F, Guillemin GJ, Heng B.
Viruses
in glioblastoma: an update on evidence and clinical trials.
BJC
Rep. 2024 Apr 19;2(1):33. doi:
10.1038/s44276-024-00051-z.
PMID:
39516641. Review. ˍ
Grishin AS, Achkasova KA, Kukhnina LS, Sharova VA, Ostapyuk MV,
Yashin KS.
Peritumoral
Brain Zone in Astrocytoma: Morphology, Molecular Aspects, and
Clinical Manifestations (Review).
Sovrem
Tekhnologii Med. 2024 Apr 27;16(2):79-88. doi:
10.17691/stm2024.16.2.08. PMID:
39539752. Review. ˍ
Bruzzaniti P, Pennisi G, Lapolla P, Familiari P, Maiola V,
Quintiliani C, Alò P, Relucenti M, La Pira B, D'Andrea G.
Cerebellopontine
angle pilocytic astrocytoma in adults: A systematic review.
Surg
Neurol Int. 2024 Oct 4;15:363. doi:
10.25259/SNI_539_2024. PMID:
39524593. Review. ˍ
Michalska-Foryszewska A, Bujko M, Kwiatkowska-Miernik A, Ziemba K,
Sklinda K, Walecki J, Mruk B.
The
peritumoral brain zone in glioblastoma: a review of the
pretreatment approach.
Pol
J Radiol. 2024 Oct 11;89:e480-e487. doi:
10.5114/pjr/192044. PMID:
39507892. Review. ˍ
Goethe E, Rao G.
Supramarginal
Resection of Glioblastoma: A Review.
Neurosurg
Clin N Am. 2024 Oct 16;36(1):83-89. doi:
10.1016/j.nec.2024.08.007. PMID:
39542552. Review˰ ˍ
Ali Ibrahim Mze A, Abdul Rahman A.
Repurposing
the antipsychotic drug penfluridol for cancer treatment (Review).
Oncol
Rep. 2024 Oct 25;52(6):174. doi:
10.3892/or.2024.8833. PMID:
39513619. Review. ˍ
Jacome MA, Wu Q, Piña Y, Etame AB.
Evolution
of Molecular Biomarkers and Precision Molecular Therapeutic
Strategies in Glioblastoma.
Cancers
(Basel). 2024 Oct 29;16(21):3635. doi:
10.3390/cancers16213635. PMID:
39518074. Review. ˍ
Mofatteh M, Arfaie S, Mashayekhi MS, Pearl PL, Das S, Cohen-Gadol
A.
Editorial:
Seizures in brain tumors.
Front
Surg. 2024 Oct 29;11:1504572. doi:
10.3389/fsurg.2024.1504572. PMID:
39534693. Editorial. ˍ
Zeng Y, Tao G, Zeng Y, He J, Cao H, Zhang L.
Bibliometric
and visualization analysis in the field of epigenetics and glioma
(2009-2024).
Front
Oncol. 2024 Oct 29;14:1431636. doi:
10.3389/fonc.2024.1431636. PMID:
39534093. Bibliometric analysis. ˍ
Alrasheed AS, Aleid AM, Alharbi RA, Alhodibi MH, Alhussain AA,
Alessa AA, Almalki SF.
Brainstem
Toxicity Following Proton Beam Radiation Therapy in Pediatric
Brain Tumors: A Systematic Review and Meta-Analysis.
Cancers
(Basel). 2024 Oct 30;16(21):3655. doi:
10.3390/cancers16213655. PMID:
39518092. Review. ˍ
Wang C, Yu Y, Wang Y, Yu J, Zhang C.
Utility
and Safety of 5-ALA Guided Surgery in Pediatric Brain Tumors: A
Systematic Review.
Cancers
(Basel). 2024 Oct 30;16(21):3677. doi:
10.3390/cancers16213677. PMID:
39518115. Review. ˍ
Kricha A, Bouchmaa N, Ben Mkaddem S, Abbaoui A, Ben Mrid R, El
Fatimy R.
Glioblastoma-associated
macrophages: A key target in overcoming glioblastoma therapeutic
resistance.
Cytokine
Growth Factor Rev. 2024 Oct 31:S1359-6101(24)00088-1.
doi:
10.1016/j.cytogfr.2024.10.009. PMID:
39510901. Review˰ ˍ
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A,
Maccari M, Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller
M, Preusser M, Simonelli M, Lombardi G.
PARP
inhibitors in gliomas: Mechanisms of action, current trends and
future perspectives.
Cancer
Treat Rev. 2024 Nov 5;131:102850. doi:
10.1016/j.ctrv.2024.102850. PMID:
39531943. Review. ˍ
Dehghan N, Mousavikia SN, Qasempour Y, Azimian H.
Radiation-induced
senescence in glioblastoma: An overview of the mechanisms and
eradication strategies.
Life
Sci. 2024 Nov 5;359:123218. doi:
10.1016/j.lfs.2024.123218. PMID:
39510171. Review˰ ˍ
Imran M, Altamimi ASA, Babu MA, Goyal K, Kaur I, Kumar S, Sharma
N, Kumar MR, Alanazi FJ, Alruwaili AN, Aldhafeeri NA, Ali
H.
Non-coding
RNAs (ncRNAs) as therapeutic targets and biomarkers in
oligodendroglioma.
Pathol
Res Pract. 2024 Nov 6;264:155708. doi:
10.1016/j.prp.2024.155708. PMID:
39531874. Review˰ ˍ
Zhou D, Zhu X, Xiao Y.
Advances
in CAR-T therapy for central nervous system tumors.
Biomark
Res. 2024 Nov 6;12(1):132. doi:
10.1186/s40364-024-00679-6. PMID:
39506843. Review. ˍ
Horsley PJ, Bailey DL, Schembri G, Hsiao E, Drummond J, Back MF.
The
role of amino acid PET in radiotherapy target volume delineation
for adult-type diffuse gliomas: A review of the literature.
Crit
Rev Oncol Hematol. 2024 Nov 8;205:104552. doi:
10.1016/j.critrevonc.2024.104552. PMID:
39521308. Review. ˍ
Richard SA.
The
pivotal role of autophagy in the pathogenesis and therapy of
medulloblastoma.
Future
Oncol. 2024 Nov 8:1-12. doi:
10.1080/14796694.2024.2420629. PMID:
39513232. Review˰ ˍ
Willmann J, Balermpas P, Rimner A,
Appelt AL, Vasquez Osorio EM, Rønde HS, Day
M, Embring A, Gabryś D, Guren MG, Hoskin P, Massaccesi M,
Mayo C, Murray L, Nieder C,
Guckenberger M, Andratschke N.
Ongoing
prospective studies on reirradiation: A systematic review of a
clinical trials database.
Radiother
Oncol.
2024 Nov 10;202:110624. doi:
10.1016/j.radonc.2024.110624. PMID:
39532233. Review. ˍ